ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 193 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | -100.0% | 37 | -99.1% | 0.00% | – |
| Q1 2024 | $193 | +135.4% | 4,160 | +140.9% | 0.00% | – |
| Q4 2023 | $82 | -33.3% | 1,727 | -50.5% | 0.00% | – |
| Q3 2023 | $123 | +68.5% | 3,490 | +119.5% | 0.00% | – |
| Q2 2023 | $73 | -36.5% | 1,590 | -45.4% | 0.00% | – |
| Q1 2023 | $115 | -2.5% | 2,910 | +12.9% | 0.00% | – |
| Q4 2022 | $118 | -99.9% | 2,578 | +12.1% | 0.00% | – |
| Q3 2022 | $95,000 | +75.9% | 2,299 | +146.4% | 0.00% | – |
| Q2 2022 | $54,000 | -15.6% | 933 | +4.1% | 0.00% | – |
| Q1 2022 | $64,000 | +18.5% | 896 | +36.6% | 0.00% | – |
| Q4 2021 | $54,000 | +12.5% | 656 | +21.7% | 0.00% | – |
| Q3 2021 | $48,000 | -66.9% | 539 | -65.0% | 0.00% | – |
| Q2 2021 | $145,000 | +72.6% | 1,539 | +107.1% | 0.00% | – |
| Q1 2021 | $84,000 | -17.6% | 743 | 0.0% | 0.00% | – |
| Q4 2020 | $102,000 | +72.9% | 743 | +2.2% | 0.00% | – |
| Q3 2020 | $59,000 | -29.8% | 727 | -32.7% | 0.00% | – |
| Q2 2020 | $84,000 | +3.7% | 1,081 | -41.1% | 0.00% | – |
| Q1 2020 | $81,000 | +350.0% | 1,835 | +322.8% | 0.00% | – |
| Q4 2019 | $18,000 | +80.0% | 434 | +70.2% | 0.00% | – |
| Q3 2019 | $10,000 | -99.4% | 255 | -98.9% | 0.00% | -100.0% |
| Q1 2017 | $1,641,000 | -5.7% | 24,225 | -2.1% | 0.00% | -25.0% |
| Q4 2016 | $1,740,000 | -0.9% | 24,750 | 0.0% | 0.00% | +33.3% |
| Q3 2016 | $1,755,000 | +45.0% | 24,750 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,210,000 | -22.7% | 24,750 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,566,000 | -45.4% | 24,750 | -3.3% | 0.00% | -57.1% |
| Q4 2015 | $2,870,000 | +7.8% | 25,590 | -7.5% | 0.01% | +16.7% |
| Q3 2015 | $2,662,000 | – | 27,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
| Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
| Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
| AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
| EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
| FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
| HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
| Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |